Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma".

Evens, A M; Carson, K R; Kolesar, J; Nabhan, C; Helenowski, I; Islam, N; Jovanovic, B; Barr, P M; Caimi, P F; Gregory, S A; Gordon, L I

Evens, A M; Carson, K R; Kolesar, J; Nabhan, C; Helenowski, I; Islam, N; Jovanovic, B; Barr, P M; Caimi, P F; Gregory, S A; Gordon, L I.

Afiliação

Evens AM; Division of Hematology/Oncology, Tufts Medical Center, Boston.
Carson KR; Division of Hematology/Oncology, Washington University School of Medicine, St. Louis.
Kolesar J; School of Pharmacy, University of Wisconsin Carbone Cancer Center, Madison.
Nabhan C; Medicine, Division of Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge.
Helenowski I; University of Massachusetts Medical Center, Worcester.
Islam N; University of Massachusetts Medical Center, Worcester.
Jovanovic B; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago.
Barr PM; Division of Hematology/Oncology, University of Rochester Medical Center, Rochester.
Caimi PF; Hematology and Oncology, University Hospitals Case Medical Center, Cleveland.
Gregory SA; Division of Hematology and Medical Oncology, Rush University Medical Center, Chicago.
Gordon LI; Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.

Ann Oncol ; 25(7): 1449, 2014 07.

Article em En | MEDLINE | ID: mdl-32018560

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google